Gordon, Jennifer, Chenji, Sneha, Di Florio, Arianna ![]() |
Preview |
PDF
- Accepted Post-Print Version
Download (173kB) | Preview |
Abstract
Premenstrual dysphoric disorder (PMDD) is a depressive disorder that affects 1–3% of individuals assigned female at birth.1 It is characterised by psychiatric symptoms during the luteal phase, which subside post-menstruation. On behalf of the International Association for Premenstrual Disorders (IAPMD), we wish to highlight suicidality as a symptom of PMDD, which should be investigated for possible inclusion in its diagnostic criteria. Suicide is a leading cause of death in reproductive-aged individuals;2 improved identification and treatment of underlying conditions such as PMDD are key to addressing this public health crisis. It is also worth noting that diagnostic criteria for other depressive disorders, namely major depressive disorder and bipolar disorder II, list suicidality in the DSM-5-TR and ICD-11.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Schools > Medicine Research Institutes & Centres > MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) |
Publisher: | Elsevier |
ISSN: | 2215-0366 |
Date of First Compliant Deposit: | 1 October 2024 |
Date of Acceptance: | 3 September 2024 |
Last Modified: | 19 Mar 2025 02:45 |
URI: | https://orca.cardiff.ac.uk/id/eprint/172035 |
Actions (repository staff only)
![]() |
Edit Item |